Trilogy Capital’s iShares Emerging Markets Equity Factor ETF EMGF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-363,541
Closed -$16.2M 321
2024
Q1
$16.2M Sell
363,541
-27,252
-7% -$1.17M 0.93% 30
2023
Q4
$16.7M Sell
390,793
-19,113
-5% -$797K 1.04% 28
2023
Q3
$16.8M Sell
409,906
-6,942
-2% -$292K 1.13% 29
2023
Q2
$17.7M Sell
416,848
-11,133
-3% -$459K 1.13% 25
2023
Q1
$17.8M Buy
427,981
+10,921
+3% +$459K 1.26% 30
2022
Q4
$17.1M Buy
417,060
+31,822
+8% +$1.29M 1.21% 25
2022
Q3
$14.8M Buy
385,238
+9,496
+3% +$403K 1.33% 22
2022
Q2
$16.1M Buy
375,742
+9,542
+3% +$436K 1.4% 22
2022
Q1
$17.7M Buy
366,200
+18,688
+5% +$933K 1.27% 26
2021
Q4
$17.8M Buy
+347,512
New +$17.9M 1.33% 24

Other funds holding EMGF

Trilogy Capital's EMGF Position: Q2 2024 in Review

Trilogy Capital sold out of iShares Emerging Markets Equity Factor ETF (EMGF) in Q2 2024, closing a stake of 363,541 shares — an estimated $16.2M sold.

Trilogy Capital first reported a position in EMGF in Q4 2021 and held it in 10 quarters. The position peaked at $17.8M in Q1 2023. 127 funds tracked by Wall St. Rank hold EMGF as of Q2 2024.

  • Trilogy Capital reported no remaining iShares Emerging Markets Equity Factor ETF position as of Q2 2024 after selling out during the quarter.
  • Trilogy Capital sold 363,541 iShares Emerging Markets Equity Factor ETF shares in Q2 2024, an estimated $16.2M.
  • Trilogy Capital first reported a position in iShares Emerging Markets Equity Factor ETF in Q4 2021 and held it in 10 quarters.
  • Trilogy Capital's iShares Emerging Markets Equity Factor ETF position peaked at $17.8M in Q1 2023.
  • 127 funds tracked by Wall St. Rank held iShares Emerging Markets Equity Factor ETF as of Q2 2024.

Based on Trilogy Capital's 13F filing for Q2 2024, filed 23 Jul 2024.